I think the news is too important to withhold. Possibly even material. This final pre-clinal testing confirms we have the "complete vaccine". Having this info allows for filing of the IND app with the FDA. Pretty big deal. The company isn't going to delay nor miss out on pr'ing what should be a very important trial for fighting the pandemic. I get your point though. It makes sense, having NGIO trading to take advantage of news flow is important.